Table 2: Intensive care-related risk factors of adverse outcome early after ICU discharge.

Factor Group A (n = 13) Group B (n = 11) Group C (n = 130) p-value
ICU LOS (days) 13 (7-26) 21 (14-34) 11 (6-19) 0.061
Length of CVC (days) 13 (7-33) 21 (14-35) 11 (6-21) 0.068
Length of MV (days) 8 (4-12) 13 (5-26) 7 (3-13) 0.324
Length of norepinephrine support (days) 5 (4-15) 15 (2-21)* 3 (0-8) 0.012
CVVHDF 3 (23.1) 1 (9.1) 15 (11.5) 0.456
Tracheostomya 3 (23.1) 3 (27.3) 21 (16.1) 0.557
CVCa 13 (100) 11 (100) 112 (86.1) 0.152
Nasogastric tubea 8 (61.5) 8 (72.7) 58 (44.6) 0.120
Colonization with MDR pathogena 9 (69.2) 7 (63.6) 60 (46.1) 0.175
Weekday dischargea 11 (84.6) 11 (100) 115 (88.4) 0.439
Morning shift dischargea 10 (76.9) 10 (90.1) 100 (76.9) 0.560
In hospital discharge 10 (76.9) 6 (54.5) 86 (66.1) 0.513

*Significantly different compared to Group C; Data are no. (%) of patients or median (IQR).

LOS: Length of Stay; CVC: Central Venous Catheter; MV: Mechanical Ventilation; CVVHDF: Continuous Veno-Venous Hemodiafiltration; MDR: Multidrug-Resistant; IQR: Interquartile Range.

aAt ICU discharge.